A Phase 3 Trial of Upadacitinib for Giant-Cell Arteritis

31 Jul 2025 • 2 min • EN
2 min
00:00
02:15
No file found

Dr. Shuvro Roy and Dr. Daniel Blockmans discuss the efficacy and safety of upadacitinib as a treatment option for giant-cell arteritis.  Show reference:  https://www.nejm.org/doi/10.1056/NEJMoa2413449 

From "Neurology Minute"

Listen on your iPhone

Download our iOS app and listen to interviews anywhere. Enjoy all of the listener functions in one slick package. Why not give it a try?

App Store Logo
application screenshot

Popular categories